Covered recipient · General Payments record
MICHAEL A JANITCH
Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$9,791.33
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $319.26 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $269.20 | 15 |
| Musculoskeletal Transplant Foundation Inc. | $34.22 | 2 |
| Galderma Laboratories, L.P. | $15.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.71 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987668 | CMS |
| ABBVIE INC. | $8.26 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987670 | CMS |
| ABBVIE INC. | $40.72 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987672 | CMS |
| ABBVIE INC. | $18.81 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987674 | CMS |
| ABBVIE INC. | $23.39 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987676 | CMS |
| ABBVIE INC. | $2.71 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987678 | CMS |
| ABBVIE INC. | $19.53 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987680 | CMS |
| ABBVIE INC. | $15.34 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987682 | CMS |
| ABBVIE INC. | $25.70 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987684 | CMS |
| ABBVIE INC. | $30.19 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987686 | CMS |
| ABBVIE INC. | $29.10 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987688 | CMS |
| ABBVIE INC. | $20.45 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987690 | CMS |
| ABBVIE INC. | $15.37 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987692 | CMS |
| ABBVIE INC. | $6.54 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987694 | CMS |
| ABBVIE INC. | $2.38 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103987696 | CMS |
| Galderma Laboratories, L.P. | $15.84 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145306501 | CMS |
| Musculoskeletal Transplant Foundation Inc. | $14.05 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128565579 | CMS |
| Musculoskeletal Transplant Foundation Inc. | $20.17 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128567347 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.